KR20100074382A - Fermented drinks of ginseng and preparation method thereof - Google Patents
Fermented drinks of ginseng and preparation method thereof Download PDFInfo
- Publication number
- KR20100074382A KR20100074382A KR1020080132788A KR20080132788A KR20100074382A KR 20100074382 A KR20100074382 A KR 20100074382A KR 1020080132788 A KR1020080132788 A KR 1020080132788A KR 20080132788 A KR20080132788 A KR 20080132788A KR 20100074382 A KR20100074382 A KR 20100074382A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- lactobacillus
- fermentation
- lactic acid
- hours
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 103
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 99
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 99
- 241000208340 Araliaceae Species 0.000 title claims abstract 20
- 235000019985 fermented beverage Nutrition 0.000 title description 8
- 238000002360 preparation method Methods 0.000 title 1
- 241000186660 Lactobacillus Species 0.000 claims abstract description 14
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 14
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 11
- 241000186840 Lactobacillus fermentum Species 0.000 claims abstract description 9
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 7
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 6
- 238000010025 steaming Methods 0.000 claims abstract description 5
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 71
- 241000894006 Bacteria Species 0.000 claims description 37
- 239000004310 lactic acid Substances 0.000 claims description 35
- 235000014655 lactic acid Nutrition 0.000 claims description 35
- 238000000855 fermentation Methods 0.000 claims description 31
- 230000004151 fermentation Effects 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 7
- 230000008961 swelling Effects 0.000 claims description 5
- 241000186000 Bifidobacterium Species 0.000 claims description 4
- 102000004139 alpha-Amylases Human genes 0.000 claims description 4
- 108090000637 alpha-Amylases Proteins 0.000 claims description 4
- 229940024171 alpha-amylase Drugs 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 239000000843 powder Substances 0.000 abstract description 33
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 30
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract description 5
- 230000001007 puffing effect Effects 0.000 abstract description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 2
- 229940009291 bifidobacterium longum Drugs 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 84
- FVIZARNDLVOMSU-UHFFFAOYSA-N ginsenoside K Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O FVIZARNDLVOMSU-UHFFFAOYSA-N 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 229930182490 saponin Natural products 0.000 description 8
- 150000007949 saponins Chemical class 0.000 description 8
- 235000017709 saponins Nutrition 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000021107 fermented food Nutrition 0.000 description 4
- 229930182494 ginsenoside Natural products 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000013618 yogurt Nutrition 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000186869 Lactobacillus salivarius Species 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- -1 fatty acid esters Chemical class 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000726109 Bathymodiolus thermophilus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001249696 Senna alexandrina Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 인삼발효음료 및 그의 제조방법에 관한 것으로, 보다 상세하게는 본 발명은 인삼분말에 유산균을 접종하고, 발효시키는 단계를 포함하는 인삼발효음료의 제조방법 및 전기 방법으로 제조한 인삼발효음료에 관한 것이다.The present invention relates to a ginseng fermented beverage and a method for preparing the same, and more particularly, to a ginseng fermented beverage prepared by the method and an electric method of the ginseng fermented beverage comprising the step of inoculating and fermenting lactic acid bacteria in ginseng powder. It is about.
일반적으로, 고려인삼(Panax ginseng C.A. Mayer)은 전통의학의 임상기록을 근거로 하여 그 효능에 대한 인식과 신뢰가 매우 높은 편인데(참조: 한국인삼연초연구원, 고려인삼, p.89-94, 1994), 일반화학 성분분석 결과 인삼은 탄수화물이 약 60%, 조단백질 10-11%, 조섬유 7-8%, 조지방 약 1-2%, 회분 3-4%로 구성되었고, 인삼의 유효성분으로 알려진 사포닌(saponin)의 함량은 4-10% 수준으로 알려져 있고, 사포닌의 3번, 6번 탄소에 결합한 배당체의 종류, 위치, 수에 따라 항암, 당뇨개선, 노화방지 등 다양한 생리조절기능이 나타나는 것으로 알려져 있다(참조: 한국인삼사 편집위원회, 한국인삼사, p.132-346, 동일문화사, 2002). 최근에는 위장질 환의 원인균으로 잘 알려진 헬리코박터균(Helicobacter pylori)에 대해 위장세포에 대한 부착을 억제하거나 감염 후, 생성되는 염증반응의 개선인자로서 인삼의 분자생물학적 작용기전 등 인삼의 기능성과 효능에 대하여 다각적인 해석이 이루어지고 있다(참조: Lee J.H., et al., Planta Med., 70:615-619, 2004; Park S, et al., Dig. Dis. and Sci., 50:1218-1227, 2005; Hahm K.B. et al., Cancer Prev. Res., 10:102-110, 2005).In general, Korean ginseng (Panax ginseng CA Mayer) is highly recognized and trusted for its efficacy based on the clinical records of traditional medicine (see Korea Ginseng and Tobacco Research Institute, Korea Ginseng, p.89-94, 1994), As a result of general chemical composition analysis, ginseng is composed of about 60% carbohydrate, 10-11% crude protein, 7-8% crude fiber, 1-2% crude fat, and 3-4% ash. The content of saponin is known to be 4-10%, and various physiological control functions such as anticancer, diabetes improvement, and anti-aging appear depending on the type, location, and number of glycosides bound to carbon 3 and 6 of saponin. It is known (Ref .: Korean Ginseng History Editorial Committee, Korean Ginseng History, p.132-346, Ho Chi Culture History, 2002). Recently, Helicobacter pylori, a well known causative agent of gastrointestinal diseases, suppresses adhesion to gastrointestinal cells or improves the inflammatory response generated after infection. Multiple interpretations are being made (Lee JH, et al., Planta Med., 70: 615-619, 2004; Park S, et al., Dig. Dis. And Sci., 50: 1218-1227, 2005; Hahm KB et al., Cancer Prev. Res., 10: 102-110, 2005).
한편, 발효유, 치즈, 김치, 된장과 같은 발효식품은 인류가 기원전 3000년경부터 섭취해 왔는데 각 지역의 토착미생물이 식품원료에 자연 접종된 결과 생성된 것으로 독특한 관능특성을 갖는 지역 고유의 식문화를 형성하는데 크게 기여하였다. 게다가 발효식품의 생리활성 작용이 알려지면서 이제 발효식품은 세계적으로 건강기능성 노화예방 식품으로 인식되고 있다. 특히, 락토바실러스 및 비피도박테리움과 같은 유산균은 당류를 발효하여 젖산을 생성하는 세균으로서 다양한 미생물이 존재하는 사람의 장내에서 우세균으로 분포하여 체내 유익균의 성장을 촉진하는 생균 활성제(probiotics)로서 위장기능 개선, 체내 콜레스테롤 흡수저해, 면역조절, 영양소의 흡수 및 이용율을 높히는 등 다양한 질병 예방효과와 생리조절작용을 하는 것으로 밝혀진 각광받는 건강기능성 식품소재이다(참조: Goldin, B.R., Br. J. Nutr., 80:203-207, 1998; Fuller R., J. Applied Bacteriology, 66:365-378, 1989).On the other hand, fermented foods such as fermented milk, cheese, kimchi and soybean paste have been ingested by humans since 3,000 BC, and are produced as a result of the natural inoculation of indigenous microorganisms in each region. It greatly contributed to this. In addition, as the physiological activity of fermented foods is known, fermented foods are now recognized as health functional anti-aging foods worldwide. In particular, lactic acid bacteria, such as Lactobacillus and Bifidobacterium, are bacteria that ferment sugars to produce lactic acid, which are distributed as dominant bacteria in the intestines of humans in which various microorganisms exist, and promote the growth of beneficial bacteria in the body. It is a well-known health functional food material that has been shown to have various disease prevention effects and physiological control functions, such as improving function, lowering cholesterol absorption in the body, regulating immunity, increasing absorption and utilization of nutrients (Goldin, BR, Br. J. Nutr., 80: 203-207, 1998; Fuller R., J. Applied Bacteriology, 66: 365-378, 1989).
과거에는 주로 우유를 이용하여 유산균 발효음료로서 제조하여 왔으나 유당 불내증 환자나 우유의 콜레스테롤함량이 건강에 영향을 줄 수 있다는 단점이 있고 (참조: Shah N.P., J. Dairy Sci., 83:894-907, 2000; Shah N.P., Food Technol., 55:46-53, 2005), 최근 캡슐, 타블렛, 동결건조제품 등 다양한 형태의 건강기능식품수요가 증가하면서 인삼, 콩, 쌀, 감자, 양배추, 알로에, 매실, 한약재, 녹차, 비타민A와 C 등 여러가지 식품소재를 이용하여 발효하거나 또는 첨가하여 식품의 기능성 강화는 물론 관능적 품질을 향상시킨 발효식품으로서 개발하려는 시도가 이루어지고 있다(참조: Yoon K.Y., et al., Bioresource Technol., 97:1427-1430, 2006; Lee, I.S. and Paek, K.Y., Korean J. Food Sci.Techol., 35:235-241, 2003; Lee, I.S., et al., J. Korean Soc. Food Nutr., 31:411-416, 2002; Han, M.J. and Lee, Y.K., Kor. J. Food Sci.Techol., 35:173-175, 1993; Hong, O.S., et al., Korean J. Food Sci. Technol., 23:587-592, 1991; Goh, J.S., et al., J. Dairy Sci,. 15:216-225, 1996; Chun, S.H., et al., J. Korean Soc. Food Sci. Nutr., 13:71-77, 2000; Bang, B.H. and Park, H.H., J. Korean Soc. Food Sci. Nutr., 29:854-859, 2000). 그러나, 인삼의 경우에는 그다지 주목할 만한 결과를 얻지 못하였는데, 이는 인삼이 정상적으로 발효되지 않았기 때문이다. 만일, 인삼을 발효시킬 수 있다면, 인삼의 성분에 발효로 인하여 유용성분이 추가되어, 부가가치가 높은 제품을 개발할 수 있을 것으로 예상되고 있으나, 아직까지는 별다른 성과가 없는 실정이다.In the past, it has been mainly used as a lactobacillus fermented beverage using milk. However, lactose intolerance and the cholesterol content of milk may affect health (see Shah NP, J. Dairy Sci., 83: 894-907). , 2000; Shah NP, Food Technol., 55: 46-53, 2005). Recently, demand for health foods in various forms, such as capsules, tablets, and lyophilized products, has increased, such as ginseng, soybeans, rice, potatoes, cabbage, aloe, Attempts have been made to ferment or add fermented foods to improve the organoleptic quality as well as to enhance the sensory quality by using various food materials such as plum, Chinese herbal medicine, green tea, vitamin A and C. (Yoon: KY, et. al., Bioresource Technol., 97: 1427-1430, 2006; Lee, IS and Paek, KY, Korean J. Food Sci. Techol., 35: 235-241, 2003; Lee, IS, et al., J. Korean Soc.Food Nutr., 31: 411-416, 2002; Han, MJ and Lee, YK, Kor.J. Food Sci.Techol., 35: 173-17 5, 1993; Hong, OS, et al., Korean J. Food Sci.Technol., 23: 587-592, 1991; Goh, JS, et al., J. Dairy Sci ,. 15: 216-225, 1996 Chun, SH, et al., J. Korean Soc.Food Sci.Nutr., 13: 71-77, 2000; Bang, BH and Park, HH, J. Korean Soc.Food Sci.Nutr., 29: 854 -859, 2000). However, in the case of ginseng did not get noticeable results because the ginseng did not ferment normally. If it is possible to ferment ginseng, it is expected that a useful ingredient is added to the ingredients of ginseng to develop a high value-added product, but there are no results.
이에, 본 발명자들은 인삼을 발효시킬 수 있는 방법을 개발하고자 예의 연구노력한 결과, 백삼 또는 홍삼분말에 특정 유산균 8종을 적어도 1종 이상 접종하고, 배양할 경우, 백삼 또는 홍삼분말을 효과적으로 발효시킬 수 있음을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made intensive studies to develop a method for fermenting ginseng, and as a result of inoculating at least one or more of 8 kinds of lactic acid bacteria in white ginseng or red ginseng powder, and when incubated, white ginseng or red ginseng powder can be effectively fermented. It was confirmed that the present invention, the present invention was completed.
결국, 본 발명의 주된 목적은 인삼분말을 발효시켜서 인삼발효음료를 제조하는 방법을 제공하는 것이다.After all, the main object of the present invention is to provide a method for producing a ginseng fermented beverage by fermenting ginseng powder.
본 발명의 다른 목적은 전기 방법으로 제조된 인삼발효음료를 제공하는 것이다.Another object of the present invention to provide a ginseng fermented beverage prepared by the electric method.
본 발명의 상기한 바와 같은 기술적 과제는 하기 기술적 수단을 통해 달성될 수 있다.Technical problem as described above of the present invention can be achieved through the following technical means.
(1) 백삼 또는 홍삼분말에 락토바실러스 플란타룸(L. plantarum), 락토바실러스 카제이(L. casei), 락토바실러스 람노수스(L. rhamnosus), 락토바실러스 애시도필루스(L. acidophilus), 락토바실러스 류테리(L. reuteri), 락토바실러스 퍼멘텀(L. fermentum) 및 비피도박테리움 롱검(B. longum)로 구성된 그룹으로부터 선택되는 1종의 유산균을 접종하여 배양하는 단계를 포함하는 인삼발효물의 제조방법.(1) Lactobacillus plantarum, Lactobacillus casi (L. casei), Lactobacillus rhamnosus, Lactobacillus ashdophylus on white or red ginseng powder Inoculating and incubating one species of lactic acid bacteria selected from the group consisting of L. reuteri, L. fermentum, and L. fermentum and Bifidobacterium long gum. Ginseng fermentation method.
(2) 인삼을 증삼한 후 수분함량이 10~15%이하가 되도록 건조하는 단계; 상기 건조된 인삼을 팽화처리하는 단계; 상기 팽화처리된 인삼에 락토바실러스 플란타룸 MG208, 락토바실러스 카제이 MG311, 락토바실러스 람노수스 KG315, 락토바실러스 애시도필루스 MG501C, 락토바실러스 루터리 MG505, 락토바실러스 퍼멘텀 MG590 및 비피도박테리움 롱검 MG723으로 구성된 군에서 선택되는 균주를 첨가하여 배양하는 단계를 포함하는 인삼발효물의 제조방법(2) drying the ginseng so that the water content is less than 10-15%; Swelling the dried ginseng; Lactobacillus plantarum MG208, Lactobacillus casei MG311, Lactobacillus rhamnosus KG315, Lactobacillus ashdophyllus MG501C, Lactobacillus lumentium MG505, Lactobacillus fermentum MG590 and Bifidobacterium long gum Ginseng fermentation method comprising the step of culturing by adding a strain selected from the group consisting of MG723
(3) 상기 2항에 있어서, 증삼은 100℃~120℃의 증기로 4시간 이상 10시간 이내로 찌는 단계를 포함하는 것을 특징으로 하는 인삼발효물의 제조방법(3) The method of claim 2, wherein the ginseng is steamed at 100 ℃ ~ 120 ℃ steam steaming for more than 4 hours to less than 10 hours
(4) 상기 2항에 있어서, 팽화처리는 압력 5 ~ 10kg/㎠, 온도 110 ~ 120℃ 조건하에 5 ~ 15분 가량 팽화처리하는 것을 특징으로 하는 인삼발효물의 제조방법.(4) The method for producing a ginseng fermented product according to item 2, wherein the expansion treatment is expanded for about 5 to 15 minutes under pressure of 5 to 10 kg / cm 2 and a temperature of 110 to 120 ° C.
(5) 상기 2항에 있어서, 팽화처리한 인삼에 정제수를 50 ~ 100중량% 투입한 후 알파-아밀라아제를 0.01 ~ 1.0중량% 투입하여 40~50℃의 온도하에 1~5 시간 가수분해하는 단계를 더 포함하는 것을 특징으로 하는 인삼발효물의 제조방법(5) the method according to claim 2, wherein 50 to 100% by weight of purified water is added to the expanded ginseng and 0.01 to 1.0% by weight of alpha-amylase is hydrolyzed for 1 to 5 hours at a temperature of 40 to 50 ° C. Ginseng fermentation method characterized in that it further comprises
(6) 제 1항 내지 제 5항에서 선택된 어느 하나의 방법으로 제조된 인삼발효물.(6) Ginseng fermented product prepared by any one of the method selected from paragraphs 1 to 5.
본 발명의 인삼발효물의 제조방법을 이용하면, 인삼분말을 유산균으로 발효시켜서 인삼의 유효성분에 유산균 발효물의 유효성분이 부가된 새로운 발효물을 제조할 수 있으므로, 인삼을 이용한 새로운 기능성 식품의 개발에 널리 활용될 수 있을 것이다.By using the ginseng fermentation method of the present invention, the ginseng powder can be fermented with lactic acid bacteria to produce a new fermented product added with the active ingredient of lactic acid bacteria fermentation to the active ingredient of ginseng, so it is widely used in the development of new functional food using ginseng. Could be utilized.
본 발명의 인삼발효음료의 제조방법은 백삼 또는 홍삼분말에 락토바실러스 플란타룸(L. plantarum), 락토바실러스 카제이(L. casei), 락토바실러스 람노수스(L. rhamnosus), 락토바실러스 애시도필루스(L. acidophilus), 락토바실러스 류테리(L. reuteri), 락토바실러스 퍼멘텀(L. fermentum) 및 비피도박테리움 롱검(B. longum)로 구성된 그룹으로부터 선택되는 적어도 1종의 유산균을 접종하여 배양하는 단계를 포함한다.The method for preparing the ginseng fermented beverage of the present invention is Lactobacillus plantarum, Lactobacillus cassia (L. casei), Lactobacillus rhamnosus, Lactobacillus ashdo on white ginseng or red ginseng powder At least one lactic acid bacterium selected from the group consisting of L. acidophilus, L. reuteri, L. fermentum and B. doum B. longum Inoculating and culturing.
본 실험에 사용되는 원료삼은 백삼 또는 홍삼이 사용될 수 있으며, 바람직하게는 이들을 각각 미분쇄하여 200 mesh 이하의 분말상태로 하여 사용할 수 있다.White ginseng or red ginseng may be used as the raw ginseng used in this experiment, and preferably, each of them may be pulverized and used as a powder of 200 mesh or less.
본 발명에서는 순수하게 인삼만을 배지성분으로 하여 발효시킬 수 있는 미생물을 선별하기 위해 먼저, 시판되는 27종의 유산균을 각각 MRS 액체배지에 접종 후 37°C에서 정치배양 하여 활성화 하였다. 그런 다음 백삼과 홍삼을 각각 농도별로 증류수에 각각 중량비로 1% ~ 10%(w/v) 첨가하여 멸균시킨 후 활성화된 각각의 유산균을 1%~5%(w/v)씩 접종하여 24∼72시간 동안 배양하여 실험에 사용하였다.In the present invention, in order to select the microorganisms that can be fermented purely with only ginseng as a medium component, 27 kinds of commercially available lactic acid bacteria were inoculated in MRS liquid medium and then incubated at 37 ° C for activation. Then, white and red ginseng were sterilized by adding 1% to 10% (w / v) in distilled water by weight, respectively, and then inoculated by 1% to 5% (w / v) of each activated lactic acid bacterium. Incubation for 72 hours was used for the experiment.
발효물이 생성되는 균주를 선별한 결과, 총 8종의 유산균 균주(L. plantarum MG208, L. casei MG311, L. rhamnosus MG315, L. acidophilus MG501, L. acidophilus MG501C, L. reuteri MG505, L. fermentum MG590, Bi. longum MG723)가 인삼분말을 배지로 이용하여 활발하게 증식하면서, pH 및 산도가 종래의 유산균과 유사한 수준을 나타내는, 인삼배양물을 생산할 수 있음을 확인하였다. As a result of screening for strains producing fermented products, a total of eight strains of lactic acid bacteria (L. plantarum MG208, L. casei MG311, L. rhamnosus MG315, L. acidophilus MG501, L. acidophilus MG501C, L. reuteri MG505, L. fermentum MG590, Bi. longum MG723) was actively grown using ginseng powder as a medium, it was confirmed that the pH and acidity can produce a ginseng culture, showing a level similar to the conventional lactic acid bacteria.
본 발명의 인삼발효물의 제조방법을 이용하면, 인삼분말을 유산균으로 발효 시켜서 인삼의 유효성분에 유산균 발효물의 유효성분이 부가된 새로운 발효물을 제조할 수 있으므로, 인삼을 이용한 새로운 기능성 식품의 개발에 널리 활용될 수 있을 것이다.By using the method of manufacturing ginseng fermentation product of the present invention, the ginseng powder can be fermented with lactic acid bacteria to prepare new fermented products added with the active ingredient of lactic acid bacteria fermentation to the active ingredient of ginseng, which is widely used in the development of new functional foods using ginseng. Could be utilized.
본 발명에서는 순수한 백삼 또는 홍삼분말을 물에 각각 1% ~ 5중량% 첨가하는 외에는 기타 배지성분은 함유할 필요가 없으며 따라서 발효후 얻어지는 결과물은 순수한 인삼발효물이다. 또한 본 발명에 따른 인삼발효물은 발효전과 발효후의 진세노사이드 형태가 전환되어지는 특징을 가진다.In the present invention, except adding 1% to 5% by weight of pure white ginseng or red ginseng powder, respectively, it is not necessary to contain other media components, and thus the result obtained after fermentation is pure ginseng fermented product. In addition, the ginseng fermentation product according to the present invention has the feature that the ginsenoside form is converted before and after fermentation.
바람직하기로는 상기 본 발명에 사용되는 원료인삼은 발효 효율을 보다 개선하기 위한 목적으로 원료인삼을 증삼한 후 일정 수분함량으로 건조한 것을 팽화처리하는 과정을 포함할 수 있다.Preferably, the raw ginseng used in the present invention may include a process of swelling the dried ginseng with a certain moisture content after increasing the raw ginseng for the purpose of further improving the fermentation efficiency.
인삼의 증삼과정은 100℃~120℃의 증기로 4시간 이상 10시간 이내로 찌는 과정에 의해 수행될 수 있으며, 증삼한 후의 수분함량은 이후 팽화처리과정에서 효과적인 팽화처리를 위해 10~15% 정도로 조절하도록 한다. 상기 온도범위나 시간을 초과하는 경우에는 조사포닌 함량의 수율향상을 기대하기 곤란하며, 이미나 이취 등 관능성이 저하할 우려가 있다. The ginseng process of ginseng can be carried out by steaming at 100 ℃ ~ 120 ℃ with steam of more than 4 hours and within 10 hours, and the water content after steaming is adjusted to 10 ~ 15% for effective swelling in the subsequent expansion process. Do it. When it exceeds the said temperature range and time, it is difficult to expect the yield improvement of a survey | investment ponin content, and there exists a possibility that functional properties, such as odor and odor, may fall.
이와 같이 건조된 인삼은 압력 5 ~ 10kg/㎠, 온도 110 ~ 120℃ 조건하에 5 ~ 15분 가량 팽화처리되며, 팽화과정에 의해 최종 발효 인삼배양액 내에 조사포닌의 함량을 증가시킬 수 있다. 상기와 같은 압력 및 온도 범위를 초과하는 경우에는 팽화처리에 따른 조사포닌 증대효과를 기대하기 곤란하고, 관능성에도 악영향을 끼칠 우려가 있어 바람직하지 않다. The dried ginseng is expanded for 5 to 15 minutes under pressure of 5 to 10 kg / cm 2 and a temperature of 110 to 120 ° C., and the content of irradiated ginseng may be increased in the final fermented ginseng culture solution by the expansion process. If the pressure and temperature range as described above are exceeded, it is difficult to expect the effect of increasing the irradiated pononine by the swelling treatment, which may adversely affect the functionality, which is not preferable.
이와 같은 원료인삼의 증삼과정과 팽화처리과정을 통해 이후 단계에서 발효에 최적화된 상태가 되어 유산균주를 첨가하여 배양시 유용한 조사포닌의 함량이 많은 인삼발효차를 얻을 수 있다.Through the ginseng process and puffing process of the raw ginseng, it is optimized for fermentation at a later stage, so that the fermented tea with high content of irradiated ginseng can be obtained by adding lactic acid bacteria.
또한 본 발명에서는 상기 팽화처리된 인삼을 세절하기 전 또는 후에 인삼에 대하여 정제수를 50 ~ 100중량% 투입한 후 알파-아밀라아제를 0.01 ~ 1.0중량% 투입하여 40 ~ 50℃의 온도하에 1~5 시간 가수분해하는 단계를 더 포함할 수 있다. 이 과정에 의해 사포닌의 수율증대 뿐만 아니라 인삼속에 함유된 전분이나 기타 유용한 물질이 가수분해되어 용출되어지는 효과를 제공할 수 있다.In addition, in the present invention, 50 to 100% by weight of purified water is added to the ginseng before or after cutting the expanded ginseng, and 0.01 to 1.0% by weight of alpha-amylase is added for 1 to 5 hours at a temperature of 40 to 50 ° C. It may further comprise the step of hydrolysis. This process not only increases the yield of saponins but also provides the effect that the starch or other useful substances contained in the ginseng are hydrolyzed and eluted.
상기 본 발명에 따라 얻어지는 발효인삼 배양액은 그래도 제품화하여도 좋고, 여기에 일반적으로 풍미를 제고하기 위한 각종 첨가제를 사용하여도 좋다. 예를 들어, 각종 당질, 유화제, 비타민, 산미료, 감미료, 과즙 등이 포함될 수 있다. 당질로는 포도당, 과당, 서당, 봉밀 등이 사용될 수 있고, 유화제로는 지방산 에스테르, 글리세린 지방산에스테르, 레시틴 등을 들 수 있다.The fermented ginseng culture solution obtained according to the present invention may still be commercialized, and various additives for enhancing flavor may be generally used. For example, various sugars, emulsifiers, vitamins, acidulants, sweeteners, juices and the like can be included. Glucose, fructose, sucrose, beeswax and the like may be used, and examples of the emulsifier include fatty acid esters, glycerin fatty acid esters, lecithin and the like.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for describing the present invention in more detail and that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention .
<실시예 1> 인삼분말을 포함하는 배지를 이용한 유산균의 배양Example 1 Culture of Lactic Acid Bacteria Using Medium Containing Ginseng Powder
먼저, 다수종의 유산균주(락토바실러스 브레비스(L. brevis), 락토바실러스 류테리(L. reuteri), 락토바실러스 플란타룸(L. plantarum), 락토바실러스 카제이(L. casei), 락토바실러스 람노수스(L. rhamnosus), 락토바실러스 애시도필루스(L. acidophilus), 락토바실러스 불가리쿠스(L. bulgaricus), 락토바실러스 스포로제네스(L. sporogenes), 락토바실러스 가스세리(L. gasseri), 락토바실러스 곤소니(L. gohnsonii), 락토바실러스 퍼멘텀(L. fermentum), 락토바실러스 살리바리우스(L. salivarius), 엔테로코커스 페슘(E. faecium), 스트렙토코커스 페칼리스(S. faecalis), 스트렙토코커스 서모필루스(S. thermophilus), 류코노스톡 시트레움(Leu. citreum), 류코노스톡 락티스(Lac. lactis), 비피도박테리움 롱검(B. longum), 비피도박테리움 서모필루스(B. thermophilus))를 포함하는 식품용 유산균주((주)메디오젠, 대한민국)에 포함된 각각의 유산균을 유산균 배양용 고체배지(MRS Agar media, Difco Inc., USA)에 도말하여 배양하고, 3주간격으로 계대배양하였다.First, a number of lactic acid strains (Lactobacillus brevis, Lactobacillus L. reuteri, Lactobacillus plantarum, Lactobacillus casse (L. casei), Lactobacillus L. rhamnosus, L. acidophilus, L. bulgaricus, L. sporogenes, L. gasseri , L. gohnsonii, L. fermentum, L. salivarius, L. salivarius, Enterococcus, E. faecium, Streptococcus pecalis, Streptococcus thermophilus, Leu. Citreum, Lec. Lactis, B. dopi B. longum, B. dop. Lactic acid bacteria for foods containing Ruth (B. thermophilus) (Mediogen, Korea) Culture to smear the respective lactic acid bacteria contained in the lactic acid bacteria for cultivation solid medium (MRS Agar media, Difco Inc., USA), which was subcultured every 3 weeks.
한편, 4년근 백삼 및 6년근 홍삼을 세절하고, 이를 미분쇄하여 200mesh 이하의 입자크기를 갖는 분말을 수득하였다. 이어, 전기 수득한 백삼 및 홍삼분말을 각각 1%(w/v) 및 5%(w/v)의 농도로 증류수에 현탁하여 각각의 배지를 수득하고, 수득한 배지에 전기 배양한 각 유산균을 1×106CFU/ml씩 접종하여 24시간 및 48시간 동안 배양하였다.Meanwhile, four-year-old white ginseng and six-year-old red ginseng were cut and finely pulverized to obtain a powder having a particle size of 200 mesh or less. Subsequently, the white and red ginseng powders obtained above were suspended in distilled water at concentrations of 1% (w / v) and 5% (w / v), respectively, to obtain respective media. 1 × 10 6 CFU / ml was inoculated and incubated for 24 and 48 hours.
<실험예 1> 인삼분말을 포함하는 배지에서 배양된 유산균의 생균수 측정Experimental Example 1 Measurement of Viable Cell Count of Lactic Acid Bacteria Cultured in a Medium Containing Ginseng Powder
전기 실시예 1에서 배양된 각 배양물 1ml을 멸균된 생리식염수 9ml과 혼합하여 희석하고, 이를 세포계수기로 계수하여 배양물 1ml에 포함된 각 유산균의 생균수를 측정하였으며, 생균수가 약 1.0×108 CFU/ml 이상인 균주를 선별하였다(참조: 표 1).1 ml of each culture cultured in Example 1 was diluted with 9 ml of sterilized physiological saline, and counted with a cell counter to measure the viable cell count of each lactic acid bacterium in 1 ml of culture. Strains of 8 CFU / ml or more were selected (see Table 1).
<표 1> 배양시간 및 배지에 포함된 백삼 또는 홍삼 분말의 함량에 따른 유산균주의 생균수(단위: 1×108CFU/ml)<Table 1> Number of live bacteria of lactic acid strains according to incubation time and the content of white ginseng or red ginseng powder in the medium (unit: 1 × 10 8 CFU / ml)
상기 표 1에서 보듯이, 생균수가 약 1.0×108 CFU/ml 이상인 균주로 8종의 유산균이 선별되었다. 선별된 유산균은 최초 접종 시 1.0×106 CFU/ml에서 인삼배지에서 배양한 후 최소 0.01×108 CFU/ml에서 최대 13.9×108 CFU/ml 로 생균수가 증가 하였으므로 인삼배지에서 유산균의 증식율은 최저 100배에서 최대 1,400배정도까지 촉진되는 것을 알 수 있었다.As shown in Table 1, 8 kinds of lactic acid bacteria were selected as strains having a viable cell number of about 1.0 × 10 8 CFU / ml or more. The selected lactic acid bacteria were cultured in ginseng medium at 1.0 × 10 6 CFU / ml at the first inoculation, and the viable cell count increased from 0.01 × 10 8 CFU / ml to 13.9 × 10 8 CFU / ml at a minimum. It can be seen that it is promoted from a minimum of 100 times to a maximum of 1,400 times.
<실험예 2> 인삼분말을 포함하는 배지에서 유산균을 배양한 배양물의 pH 측정<Experiment 2> pH measurement of the culture cultured lactic acid bacteria in a medium containing ginseng powder
전기 실시예 1에서 배양한 각 배양물의 pH를 pH 메터를 이용하여 측정하였다(참조: 표 2).The pH of each culture incubated in Example 1 was measured using a pH meter (see Table 2).
<표 2> 배양시간 및 배지에 포함된 백삼 또는 홍삼 분말의 함량에 따른 유산균 배양물의 pH<Table 2> pH of lactic acid bacteria cultures according to the incubation time and the content of white ginseng or red ginseng powder in the medium
상기 표 2에서 보듯이, 백삼 또는 홍삼분말을 포함하는 배지를 이용하여 유산균을 배양할 경우, 배양물의 pH는 3.42 내지 4.83를 나타내었다. 현재, 국내에 서 시판되는 요구르트제품의 일반적인 pH인 4.5 내지 5.0보다는 다소 낮지만, 미국에서 유통되고 있는 요구르트의 pH인 3.80 내지 4.35, 캐나다 요구르트의 pH인 3.27 내지 4.53과 비슷한 수준이었으므로, 통상적인 요구르트와 유사한 수준이라고 판단되었다.As shown in Table 2, when the lactic acid bacteria were cultured using a medium containing white ginseng or red ginseng powder, the pH of the culture was 3.42 to 4.83. Currently, it is slightly lower than the general pH of commercially available yogurt products, 4.5 to 5.0, but was similar to the pH of yogurt in the United States, 3.80 to 4.35, and the pH of Canadian yogurt, 3.27 to 4.53. It was judged to be similar to.
<실험예 3> 인삼분말을 포함하는 배지에서 유산균을 배양한 배양물의 산도 측정Experimental Example 3 Measurement of Acidity of Culture Cultured Lactic Acid Bacteria in a Medium Containing Ginseng Powder
전기 실시예 1에서 배양한 각 배양물의 산도를 식품공전 방법에 준하여 측정하였다. 즉, 전기 실시예 1에서 배양한 각 배양물에 1%(v/v) 페놀프탈레인 알코올(Phenolphthalein alcohol) 0.5 ml를 가하고, 0.1N NaOH용액으로 적정하여 엷은 홍색이 30초 유지되는 시점에서 0.1N NaOH용액의 소비량을 측정한 다음, 기준표에 의하여 산도를 산정하였다(참조: 표 3). The acidity of each culture cultured in Example 1 was measured according to the food method. That is, 0.5 ml of 1% (v / v) phenolphthalein alcohol was added to each culture cultured in Example 1, 0.1N NaOH at a point where pale redness was maintained by titration with 0.1 N NaOH solution for 30 seconds. After the consumption of the solution was measured, the acidity was calculated according to the reference table (see Table 3).
<표 3> 배양시간 및 배지에 포함된 백삼 또는 홍삼 분말의 함량에 따른 유산균 배양물의 산도<Table 3> Acidity of Lactic Acid Bacteria Culture According to Incubation Time and Content of White Ginseng or Red Ginseng Powder in Medium
상기 표 3에서 보듯이, 백삼분말을 포함하는 배지를 이용하여 유산균을 배양할 경우, 배양물의 산도는 0.05 내지 0.79를 나타내었고, 홍삼분말을 포함하는 배지를 이용하여 유산균을 배양할 경우, 배양물의 산도는 0.12 내지 0.86을 나타내었으며, 이는 통상적인 요구르트와 유사한 수준이라고 판단되었다.As shown in Table 3, when the lactic acid bacteria were cultured using a medium containing white ginseng powder, the acidity of the culture was 0.05 to 0.79, and when the lactic acid bacteria were cultured using a medium containing red ginseng powder, The acidity ranged from 0.12 to 0.86, which was determined to be similar to that of conventional yogurt.
<실험예 4> 홍삼분말을 포함하는 배지에서 L. plantarum (MG208)을 배양한 배양물내 조사포닌 함량 측정Experimental Example 4 Measurement of Irradiated Phononin Content in Cultured L. plantarum (MG208) in a Medium Containing Red Ginseng Powder
가장 효과적인 발효활성을 보인 홍삼분말을 포함하는 배지에서 L. plantarum (MG208)을 배양한 배양물내 조사포닌 함량을 식품공전의 방법에 준하여 측정하였다. 시료 5 g에 물포화 부탄올 50 ml을 가하여 80℃에서 1시간 환류추출하고 냉각 하여 여과 하였다. 이를 3 회 반복하여 얻어진 추출물 150 ml 에 증류수 20 ml 을 첨가하여 10 분간 섞은 후 상온에서 24 시간 방치하여 부탄올 층을 취하고 완전농축 하였다. 농축물에 에테르 50 ml을 첨가하고 36 ℃에서 30 분간 환류추출하여 지방을 제거한 후 109℃ 오븐에서 20 시간 동안 건조하고 조사포닌의 무게를 측정하였다. 발효전과 발효 후 홍삼의 조사포닌 함량은 표 4 에 나타내었다. The content of irradiated saponin in L. plantarum (MG208) cultured medium containing red ginseng powder showed the most effective fermentation activity. 50 ml of water-saturated butanol was added to 5 g of the sample, and the mixture was refluxed at 80 ° C. for 1 hour, cooled, and filtered. 20 ml of distilled water was added to 150 ml of the extract obtained by repeating this three times, and the mixture was mixed for 10 minutes and left at room temperature for 24 hours to obtain a butanol layer and completely concentrated. 50 ml of ether was added to the concentrate and refluxed at 36 ° C. for 30 minutes to remove fat, followed by drying in an oven at 109 ° C. for 20 hours, and weighing the irradiated saponin. The irradiated saponin content of red ginseng before and after fermentation is shown in Table 4.
<표 4> 발효전과 발효 후 홍삼의 조사포닌 함량변화 (%)<Table 4> Changes of Irradiated Phononin Contents in Red Ginseng Before and After Fermentation (%)
<실험예 5> 인삼분말을 포함하는 배지에서 유산균을 배양한 배양물의 조사포닌 내 진세노사이드 대사체인 컴파운드 K의 함량 측정Experimental Example 5 Determination of Compound K Content, a Ginsenoside Metabolite in Irradiated Cultures of Lactic Acid Bacteria in a Medium Containing Ginseng Powder
컴파운드 K는 진세노사이드의 대표적인 대사체로 알려져 있으며 몸에 흡수된 진세노사이드는 장내미생물에 의하여 생체내에서 빠르게 컴파운드 K로 전환된다.Compound K is known as a representative metabolite of ginsenosides, and ginsenosides absorbed by the body are rapidly converted into compound K in vivo by the intestinal microorganisms.
가장 효과적인 발효활성을 보인 홍삼분말을 포함하는 배지에서 L. plantarum (MG208)을 배양한 배양물의 조사포닌 내 컴파운드 K 함량을 HPLC를 이용하여 정량하였다. 시료액은 건조된 조사포닌 추출물을 10 mg/㎖로 메탄올에 녹인 후 0.45 um 시린지 필터 (Millipore)로 여과하여 제조하였고 이를 분석용 시료로 사용하였다.Compound K content in irradiated saponin of cultured L. plantarum (MG208) in a medium containing red ginseng powder showing the most effective fermentation activity was quantified using HPLC. The sample solution was prepared by dissolving the dried irradiated pohnponin extract in methanol at 10 mg / ml and filtering it with a 0.45 um syringe filter (Millipore), which was used as a sample for analysis.
HPLC는 Jasco Co. (Japan) 의 분석용 액체크로마토그라피를 사용 하였다. 칼럼은 Bondpack C18 (125Å, 10 um, 300 × 3.9 mm)을 사용하였고 이동상은 물과 아세토나이트릴을 구배 (초기 물 80% 에서 63 분 후 20%) 를 주어 1.0 ㎖/min의 속도로 용출하였다. 칼럼의 온도는 25℃로 유지하였으며 시료의 검출은 203 nm에서 측정하였다.HPLC was performed by Jasco Co. Analytical liquid chromatography of (Japan) was used. The column used Bondpack C18 (125Å, 10 um, 300 × 3.9 mm) and the mobile phase was eluted at 1.0 mL / min with a gradient of water and acetonitrile (20% after 63 minutes at 80% initial water). . The temperature of the column was maintained at 25 ° C. and the detection of the sample was measured at 203 nm.
분석결과 컴파운드 K는 57.2 분에서 용출되었으며 발효전과 발효후의 c컴파운드 K 함량을 정량한 결과는 도 1과 표 5와 같다. As a result of the analysis, compound K was eluted at 57.2 minutes, and the results of quantifying c compound K content before and after fermentation are shown in FIGS. 1 and 5.
<표 5> 발효전, 후 홍삼 조사포닌 추출물내 컴파운드 K 함량 (%)<Table 5> Compound K content in red ginseng irradiated with saponin before and after fermentation (%)
<실시예 2> <Example 2>
4년근 백삼을 120℃의 증기로 5시간 증삼한 것을 수분이 15%가 될 때까지 상온에서 건조하였다. 상기와 같이 건조된 인삼을 압력 10kg/㎠, 온도 120℃ 조건하에 10분 가량 팽화기를 이용하여 팽화처리하였다. Four-year-old white ginseng was steamed at 120 ° C. for 5 hours, and dried at room temperature until the moisture became 15%. The ginseng dried as described above was expanded for 10 minutes under a pressure of 10 kg / cm 2 and a temperature of 120 ° C. using an expander.
팽화처리된 백삼을 세절하고, 이를 미분쇄하여 200mesh 이하의 입자크기를 갖는 분말을 수득하였다. 이어, 전기 수득한 백삼분말을 각각 1%(w/v) 및 5%(w/v)의 농도로 증류수에 현탁하여 각각의 배지를 수득하고, 수득한 배지에 전기 배양한 각 유산균을 1×106CFU/ml씩 접종하여 24시간 및 48시간 동안 배양하였다.Puffed white ginseng was cut and finely ground to obtain a powder having a particle size of 200 mesh or less. Subsequently, the white ginseng powder obtained above was suspended in distilled water at concentrations of 1% (w / v) and 5% (w / v), respectively, to obtain respective media, and each lactic acid bacterium electrocultured to the obtained media was 1 ×. 10 6 CFU / ml was inoculated and incubated for 24 and 48 hours.
<실시예 3> <Example 3>
6년근 홍삼을 사용한 것을 제외하고는 실시예 2와 동일한 방법에 의해 배양하였다.The culture was carried out in the same manner as in Example 2, except that six years old red ginseng was used.
<실시예 4> <Example 4>
실시예 2에 의해 팽화처리된 백삼에 대하여 정제수를 100중량%를 투입한 후 시판 알파-아밀라아제를 0.05중량% 투입하여 50℃의 온도하에 3 시간 가수분해한 것을 세절하고, 이를 미분쇄하여 200mesh 이하의 입자크기를 갖는 분말을 수득하였다. 이어, 전기 수득한 백삼분말을 각각 1%(w/v) 및 5%(w/v)의 농도로 증류수에 현탁하여 각각의 배지를 수득하고, 수득한 배지에 전기 배양한 각 유산균을 1×106CFU/ml씩 접종하여 24시간 및 48시간 동안 배양하였다.100% by weight of purified water was added to the white ginseng treated in Example 2, followed by 0.05% by weight of commercial alpha-amylase, and the hydrolysis was carried out at 50 ° C. for 3 hours. A powder having a particle size of was obtained. Subsequently, the white ginseng powder obtained above was suspended in distilled water at concentrations of 1% (w / v) and 5% (w / v), respectively, to obtain respective media, and each lactic acid bacterium electrocultured to the obtained media was 1 ×. 10 6 CFU / ml was inoculated and incubated for 24 and 48 hours.
<실시예 5> Example 5
6년근 홍삼을 사용한 것을 제외하고는 실시예 4와 동일한 방법에 의해 배양하였다.The culture was carried out in the same manner as in Example 4 except that 6 years old red ginseng was used.
<실험예 6>Experimental Example 6
실시예 2 내지 5에서 얻은 각 배양액을 대상으로 실험예 4 및 5에서와 동일한 방법에 따라 조사포닌 함량과 컴파운드 K 함량을 조사한 결과는 표 6 및 표 7에서와 같다.According to the same method as in Experimental Examples 4 and 5 with respect to each of the cultures obtained in Examples 2 to 5, the results of irradiating the irradiated with the sapononin and the compound K content are shown in Tables 6 and 7.
<표 6> 원료삼과 발효 후 홍삼의 조사포닌 함량변화 (%)<Table 6> Changes of Irradiated Phononin Contents in Raw Ginseng and Red Ginseng after Fermentation (%)
<표 7> 원료삼과 발효 후 홍삼 조사포닌 추출물내 compound K 함량 (%)Table 7 Compound K content in raw ginseng and irradiated red ginseng irradiated after fermentation (%)
도 1은 발효전과 발효후의 c컴파운드 K 함량의 변화를 비교한 실험결과 그래프이다.1 is a graph showing the results of experiments comparing changes in c compound K content before and after fermentation.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080132788A KR20100074382A (en) | 2008-12-24 | 2008-12-24 | Fermented drinks of ginseng and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080132788A KR20100074382A (en) | 2008-12-24 | 2008-12-24 | Fermented drinks of ginseng and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100074382A true KR20100074382A (en) | 2010-07-02 |
Family
ID=42636904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080132788A KR20100074382A (en) | 2008-12-24 | 2008-12-24 | Fermented drinks of ginseng and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20100074382A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101253658B1 (en) * | 2011-03-18 | 2013-04-12 | (주)그린바이오 | Manufacturing method of treated puffing and fermentation red ginseng concentrate |
KR101394957B1 (en) * | 2012-07-10 | 2014-05-14 | 오재원 | a fermentation red ginseng process |
KR101594567B1 (en) | 2015-06-24 | 2016-02-17 | 정우석 | Manufacture Method of Ginseng Extracts |
CN107373265A (en) * | 2017-09-15 | 2017-11-24 | 北京百丰天下生物科技有限公司 | Concentrate viable bacteria quantum beverage and preparation method thereof |
CN110771875A (en) * | 2019-11-05 | 2020-02-11 | 质每(中国)有限公司 | Method for fermenting ginseng by using lactobacillus |
KR20220098447A (en) * | 2021-01-04 | 2022-07-12 | 손경순 | The methods of manufacture of functional fermented mixture extracts containing sprouts, vegetable biopharmaceuticals and red ginseng |
-
2008
- 2008-12-24 KR KR1020080132788A patent/KR20100074382A/en not_active Application Discontinuation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101253658B1 (en) * | 2011-03-18 | 2013-04-12 | (주)그린바이오 | Manufacturing method of treated puffing and fermentation red ginseng concentrate |
KR101394957B1 (en) * | 2012-07-10 | 2014-05-14 | 오재원 | a fermentation red ginseng process |
KR101594567B1 (en) | 2015-06-24 | 2016-02-17 | 정우석 | Manufacture Method of Ginseng Extracts |
CN107373265A (en) * | 2017-09-15 | 2017-11-24 | 北京百丰天下生物科技有限公司 | Concentrate viable bacteria quantum beverage and preparation method thereof |
CN110771875A (en) * | 2019-11-05 | 2020-02-11 | 质每(中国)有限公司 | Method for fermenting ginseng by using lactobacillus |
KR20220098447A (en) * | 2021-01-04 | 2022-07-12 | 손경순 | The methods of manufacture of functional fermented mixture extracts containing sprouts, vegetable biopharmaceuticals and red ginseng |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100618171B1 (en) | Fermented red ginseng containing ginseng saponin degradate and its manufacturing method | |
KR101330864B1 (en) | Preparation for fermented-red gingseng or fermented-gingseng containing increased ginsenoside rd using pectinase | |
CN102318806B (en) | Preparation method of probiotics fermented pumpkin and carrot vegetable powder | |
KR101753077B1 (en) | A method for preparing fermented ginseng extract and compositions comprising thereof | |
JP5563550B2 (en) | Antioxidants and antioxidant beverages | |
KR20170061959A (en) | Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption | |
KR101823585B1 (en) | Methods for preparing fermented ginseng extracts | |
US20230104564A1 (en) | Culture process for enhancing proliferation of lactic acid bacteria by using red ginseng | |
KR100824285B1 (en) | Processes for preparing a saccharified ginseng and ginseng extracts | |
KR20100074382A (en) | Fermented drinks of ginseng and preparation method thereof | |
KR20090083505A (en) | A method for preparing fermented ginseng of ginseng extract using lactobacillus fermentum bljh101 | |
KR20140051543A (en) | Method for producing fermented herb extract with high gaba content using lactobacillus plantarum k154 | |
KR20200054864A (en) | Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof | |
KR102044602B1 (en) | Preparation method for soybean-fermented composition having enhanced GABA, Conjugated linoleic acid and Aglycone isoflavones, combined probiotics for its fermentation and functional food of anti-diabetic and anti-obesity effects containing the soybean-fermented composition | |
KR101664380B1 (en) | Method for Making Fermented Food Containing Red Ginseng by Using Mixed Aspergillus Oryzae and Lactic Acid Bacteria | |
KR20100079874A (en) | Preparation method of fermented ginseng or fermented red ginseng with active ginsenoside heightening absroption rate using lactic acid bacteria | |
KR101980450B1 (en) | Composition of active wild-cultivated ginseng having increased ginsenoside Rd and compound K, chlorgenic acid and quercetin, and preparation method thereof | |
Song et al. | Effects of Flammulina velutipes polysaccharides on quality improvement of fermented milk and antihyperlipidemic on streptozotocin-induced mice | |
KR20130107940A (en) | Method of producing fermented red ginseng | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
CN117143769A (en) | Lactobacillus plantarum CCFM1275 capable of converting glycyrrhizic acid and rutin and soyabean glycoside | |
KR102446426B1 (en) | Bile-resistance Strengthening Culture Process Of Lactic Acid Bacteria Using Red Ginseng | |
KR101193338B1 (en) | Food composition comprising lactic acid bacteria fermented sweet potato and preparation method thereof | |
KR101771488B1 (en) | Novel Bacillus coagulans NRR1207, fermented ginseng using the same and probiotic composition containing the same | |
KR20140039742A (en) | New microorganism lactobacillus panaxicasei for fermentation of red ginseng and food composition containing fermented red ginseng produced using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
J501 | Disposition of invalidation of trial |